What I Do and Why: HBV Treatment Strategies for Diverse Patient Populations

In this interactive virtual module, expert faculty discuss how they weigh various patient factors to aid in management decisions for patients with HBV infection; topics include treatment candidacy, individualizing treatment, patient monitoring, and approaches to immune-tolerant HBV infection.

Mindie H. Nguyen, MD, MAS, AGAF, FAASLD
Program Director Steven L. Flamm, MD Physicians: maximum of 1.25 AMA PRA Category 1 Credits™ Released: July 7, 2020 Expired: July 6, 2021

Module Overview (4 minutes)

Case 1: HBeAg-Negative Woman With Chronic HBV Infection (21 minutes)

Case 2: HBeAg-Positive Man With Chronic HBV Infection (26 minutes)

Case 3: Woman With Immune-Tolerant HBV Infection (24 minutes)

Review guideline recommendations and key data on evaluating patient and disease characteristics to inform treatment candidacy and the optimal treatment approach; topics include treatment options, patient monitoring, and approaches to immune-tolerant HBV infection.

Steven L. Flamm, MD Mindie H. Nguyen, MD, MAS, AGAF, FAASLD Released: July 7, 2020